Creative Biolabs has broadened its advanced single-cell multi-omics and RNA sequencing solutions, aiming to meet the growing demand for high-resolution cellular profiling in biomedical research. The expanded suite provides end-to-end services, from single-cell transcriptome profiling to integrated multimodal and multi-omics workflows, for researchers in oncology, immunology, and neuroscience.
As life science research moves from bulk tissue profiling to single-cell resolution, dissecting cellular heterogeneity has become essential for identifying rare cell subpopulations, characterizing complex tumor microenvironments, and tracing cell lineage trajectories. To support these pipelines, Creative Biolabs offers high-throughput single-cell RNA sequencing services that provide high sensitivity and coverage across thousands of individual cells, delivering high-resolution transcriptomic insights from diverse fresh biological specimens.
The platform also features specialized single-nucleus RNA sequencing (snRNA-seq) capabilities to address the long-standing challenge of processing complex, fibrous, or biobanked archival samples. For tissues where single-cell dissociation can cause cell damage, dissociation-induced stress responses, or selective loss of fragile cell types—such as human brain, myocardium, or flash-frozen clinical biopsies—Creative Biolabs provides an optimized single-cell nuclei RNA sequencing service. By isolating intact nuclei, this approach bypasses harsh enzymatic dissociation and minimizes dissociation-related artifacts while retaining informative nuclear RNA profiles, greatly expanding the scope of clinical translational research.
Recognizing that cellular identity is orchestrated across multiple regulatory layers, Creative Biolabs goes beyond single-dimensional analysis with its high-throughput single-cell multi-omics service. This integrated platform allows simultaneous interrogation of genomic variations, epigenomic landscapes such as chromatin accessibility, cell surface proteomics (CITE-seq), and transcriptomes within identical single cells. By directly linking epigenetic regulation and genomic alterations to gene expression readouts, the service enables researchers to construct multi-dimensional cellular atlases and uncover novel therapeutic targets with unprecedented biological clarity.
"Understanding biology at single-cell and single-nucleus resolution is no longer a luxury—it is fundamental to precision medicine and biomarker discovery," said a senior scientist at Creative Biolabs. "Our goal is to provide researchers with a seamless, modular analytical ecosystem that transforms difficult biological samples into reliable, high-dimensional datasets with rigorous bioinformatics support."
Supported by advanced microfluidics technologies, stringent quality control benchmarks, and tailored bioinformatics pipelines, Creative Biolabs continues to partner with academic and biopharmaceutical research teams worldwide to unravel the complexities of human disease. The expansion matters because it directly addresses persistent bottlenecks in single-cell research, such as sample degradation and the loss of fragile cell types, while offering integrated multi-omic views that can reveal regulatory mechanisms driving disease. By making these capabilities more accessible, Creative Biolabs aims to accelerate target validation, immunology profiling, and translational drug development.
